Bayer HealthCare and Johnson & Johnson are facing a growing multidistrict litigation (MDL), consisting of numerous claims each alleging Xarelto hemorrhage. One of the most recent additions comes from a grieving widower, alleging his wife’s death was directly caused by uncontrollable Xarelto hemorrhage.
Florida plaintiff Howard R. is filing this Xarelto hemorrhage lawsuit on behalf of his deceased wife Selma R., alleging her death was caused by Xarelto hemorrhage.
According to Howard’s Xarelto lawsuit, Selma was prescribed the new generation anticoagulant in 2014 for blood clot prevention. This is a typical treatment purpose of Xarelto, which is also popularly prescribed to patients with atrial fibrillation and who are at high risk for stroke. Xarelto and other anticoagulants work by inhibiting the body’s clotting mechanism to increase ease and efficiency in the body’s circulation process.
However, this treatment mechanism also puts patients at risk for uncontrollable Xarelto hemorrhage because the body is less able to heal itself from minor internal bleeding wounds. This is reportedly what happened to Selma on Jan. 10, 2016, who had been admitted to the emergency room for cerebral brain hemorrhage.
Even with emergency medical intervention, Selma still died from her injuries, leaving her husband to later discover about the risks of Xarelto hemorrhage. Selma’s doctors…